九安医疗(002432.SZ)：拟回购3亿元-6亿元公司股份

Core Viewpoint - The company, Jiuan Medical (002432.SZ), announced a share repurchase plan with a total funding amount between 300 million RMB and 600 million RMB, aimed at maintaining company value and shareholder rights [1] Group 1: Repurchase Details - The maximum repurchase price is set at 53.5 RMB per share, which could allow for the repurchase of approximately 11,214,953 shares, representing about 2.41% of the company's total share capital, if the upper limit of the funding and price is utilized [1] - If the lower limit of the funding is used, the company could repurchase approximately 5,607,477 shares, accounting for about 1.21% of the total share capital [1] - The repurchase plan is within the authority of the board of directors and does not require shareholder meeting approval, with a maximum implementation period of three months from the board's approval date [1] Group 2: Financial Arrangements - The company has secured a loan commitment from Shanghai Pudong Development Bank, Tianjin Branch, for a maximum amount of 500 million RMB, which will cover up to 90% of the total repurchase transaction [1] - The loan has a term of no more than 36 months [1]